RxSight (RXST) Income towards Parent Company (2020 - 2026)
RxSight's (RXST) quarterly Income towards Parent Company came in at -$15.9 million in Q1 2026, down 93.94% YoY from -$262.3 million in Q1 2025, and down 73.56% on a QoQ basis from -$9.2 million in Q4 2025.
RxSight (RXST) Income towards Parent Company (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Income towards Parent Company data on file, last reported at -$15.9 million in Q1 2026.
- Quarterly Income towards Parent Company fell 93.94% year-over-year to -$15.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$46.6 million (down 76.31% YoY) and the FY2025 annual result came in at -$38.9 million, down 42.32% from the prior year.
- Income towards Parent Company eased to -$15.9 million in Q1 2026, from -$9.2 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $53.5 million in Q4 2022 to a low of -$17.6 million in Q1 2022.
- A 5-year average of -$4.1 million and a median of -$9.8 million in 2025 frame the typical range for Income towards Parent Company.
- The widest YoY moves for Income towards Parent Company: up 440.07% in 2022, down 158.57% in 2022.
- Tracing RXST's Income towards Parent Company over 5 years: stood at $53.5 million in 2022, then retreated by 7.23% to $49.6 million in 2023, then slumped by 111.78% to -$5.8 million in 2024, then sank by 56.55% to -$9.2 million in 2025, then sank by 73.56% to -$15.9 million in 2026.
- The last three Income towards Parent Company figures came in at -$15.9 million (Q1 2026), -$9.2 million (Q4 2025), and -$9.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.10 Mn |
| Mar 31, 2026 | -15.88 Mn |
| Dec 31, 2025 | -9.15 Mn |
| Sep 30, 2025 | -9.82 Mn |
| Jun 30, 2025 | -11.79 Mn |
| Mar 31, 2025 | -8.19 Mn |
| Dec 31, 2024 | -5.85 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Jun 30, 2024 | -6.08 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Dec 31, 2023 | 49.64 Mn |
| Sep 30, 2023 | -12.42 Mn |
| Jun 30, 2023 | -13.80 Mn |
| Mar 31, 2023 | -13.21 Mn |
| Dec 31, 2022 | 53.51 Mn |
| Sep 30, 2022 | -16.82 Mn |
| Jun 30, 2022 | -16.73 Mn |
| Mar 31, 2022 | -17.60 Mn |
| Dec 31, 2021 | -15.73 Mn |
| Sep 30, 2021 | -12.67 Mn |